Market Research Logo

Body Contouring - Medical Devices Pipeline Assessment, 2017

Body Contouring - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Body Contouring - Medical Devices Pipeline Assessment, 2017 provides an overview of Body Contouring currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Body Contouring pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Body Contouring under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Body Contouring and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Body Contouring under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Body Contouring Overview
3 Products under Development
3.1 Body Contouring - Pipeline Products by Stage of Development
3.2 Body Contouring - Pipeline Products by Territory
3.3 Body Contouring - Pipeline Products by Regulatory Path
3.4 Body Contouring - Pipeline Products by Estimated Approval Date
4 Body Contouring - Pipeline Products under Development by Companies
4.1 Body Contouring Companies - Pipeline Products by Stage of Development
4.2 Body Contouring - Pipeline Products by Stage of Development
5 Body Contouring Companies and Product Overview
5.1 Andrew Technology LLC Company Overview
5.1.1 Andrew Technology LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Biosculpture Technology, Inc. Company Overview
5.2.1 Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 NivaSonix, LLC Company Overview
5.3.1 NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Slender Medical Ltd. Company Overview
5.4.1 Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Zeltiq Aesthetics Inc Company Overview
5.5.1 Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Body Contouring- Recent Developments
6.1 Mar 03, 2017: ZELTIQ Showcases CoolAdvantage Petite Applicator for the CoolSculpting System at American Academy of Dermatology Annual Meeting
6.2 Mar 01, 2017: Syneron Candela Showcases UltraShape Power System at the 2017 American Academy of Dermatology (AAD) Annual Meeting
6.3 Mar 01, 2017: ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results
6.4 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance
6.5 Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
6.6 Feb 13, 2017: Allergan to Acquire Zeltiq Aesthetics for USD2.48 Billion
6.7 Feb 13, 2017: Cutera Reports Fourth Quarter and Full-Year 2016 Record Revenue and Financial Results
6.8 Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
6.9 Jan 26, 2017: CoolSculpting Announces Only FDA-Cleared Non-Invasive Treatment for Upper Arm Fat
6.10 Jan 09, 2017: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2016 Revenue and Provides 2017 Guidance
6.11 Jan 09, 2017: ZELTIQ Aesthetics Announces Commercial Leadership Transition
6.12 Jan 09, 2017: Cutera Names James A. Reinstein as its Next President and CEO
6.13 Jan 09, 2017: Cutera Announces Record Revenue and Preliminary Financial Results for Fourth Quarter and Full Year 2016
6.14 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors
6.15 Dec 29, 2016: Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares
6.16 Dec 28, 2016: Ronald Martell to Join Cytori Therapeutics’ Board of Directors
6.17 Dec 22, 2016: Cytori Therapeutics to Raise up to USD20 Million in Private Placement of Shares
6.18 Dec 14, 2016: NJ Plastic Surgeon Presents on Fat Transfer Using the HyrdaSolve Lipoplasty System at IFATS San Diego 2016
6.19 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology
6.20 Nov 29, 2016: Lutronic Raises USD43.7 Million in Rights Offering of Preferred Shares
6.21 Nov 14, 2016: Andrew Technologies to Feature Two Powerful New Studies at IFATS San Diego 2016
6.22 Nov 09, 2016: ZELTIQ Announces Third Quarter 2016 Financial Results
6.23 Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
6.24 Nov 09, 2016: Cytori Reports Third Quarter 2016 Business and Financial Results
6.25 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results
6.26 Nov 07, 2016: Cutera Reports Record Third Quarter 2016 Results
6.27 Nov 03, 2016: Cutera Elects J. Daniel Plants as Chairman of the Board
6.28 Oct 26, 2016: Clarity Skin First In Utah To Offer Breakthrough, FDA-Cleared, Non-Invasive, UltraShape Power System For Fat Destruction
6.29 Oct 26, 2016: Center City Dermatology First In Center City Philadelphia To Offer Breakthrough, FDA-Cleared, Non-Invasive, UltraShape Power System For Fat Destruction
6.30 Oct 25, 2016: First MedSpa in Dallas-Fort Worth to Offer Breakthrough, FDA-cleared, Non-Invasive, UltraShape Power System For Fat Destruction
6.31 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team
6.32 Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue
6.33 Oct 17, 2016: Andrew Technologies Announces World’s First Successful Mesenteric Fat Extraction, a Long-Awaited Breakthrough for Potential Reversal of Diabetes
6.34 Oct 12, 2016: Clarkston Dermatology First In Michigan To Offer Breakthrough, FDA-Cleared, Non- Invasive, UltraShape Power System For Fat Destruction
6.35 Oct 11, 2016: Cutera Announces Preliminary Record Third Quarter 2016 Revenue
6.36 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
6.37 Oct 04, 2016: LaserMed Skin & Vein Clinic First In Southeast To Offer Breakthrough, FDA-Cleared, Non-Invasive, UltraShape Power System For Fat Destruction
6.38 Sep 19, 2016: Two New Studies Demonstrate Advantages of Andrew Technologies’ HydraSolve as the Company Heads to ASPS 2016
6.39 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
6.40 Aug 18, 2016: Cutera Announces Management Changes
6.41 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation
6.42 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results
6.43 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team
6.44 Aug 08, 2016: ZELTIQ Announces Second Quarter 2016 Financial Results
6.45 Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09
6.46 Aug 04, 2016: Cytori Reports Second Quarter 2016 Business and Financial Results
6.47 Aug 01, 2016: Cutera Reports Second Quarter 2016 Results
6.48 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
6.49 Jul 18, 2016: Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction
6.50 Jun 27, 2016: ZELTIQ Announces Global Commercial Launch of the CoolAdvantage Applicator for the CoolSculpting System
6.51 Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations
6.52 Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director
6.53 Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results
6.54 May 26, 2016: Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management
6.55 May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
6.56 May 19, 2016: Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
6.57 May 16, 2016: Valeant Pharmaceuticals Provides Update on Regulatory Matters
6.58 May 10, 2016: Cytori Reports First Quarter 2016 Business and Financial Results
6.59 May 10, 2016: ZELTIQ Announces First Quarter 2016 Financial Results
6.60 Mar 31, 2016: Alma Lasers to Launch Accent Prime, a Cutting-Edge Platform which Doubles the Speed of Body Contouring and Skin Tightening Treatments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Body Contouring - Pipeline Products by Stage of Development
Table 2: Body Contouring - Pipeline Products by Territory
Table 3: Body Contouring - Pipeline Products by Regulatory Path
Table 4: Body Contouring - Pipeline Products by Estimated Approval Date
Table 5: Body Contouring Companies - Pipeline Products by Stage of Development
Table 6: Body Contouring - Pipeline Products by Stage of Development
Table 7: Andrew Technology LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 8: HydraSolve Lipoplasty System - Visceral Fat - Product Status
Table 9: HydraSolve Lipoplasty System - Visceral Fat - Product Description
Table 10: Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 11: Airbrush Liposculptor IIE - Product Status
Table 12: Airbrush Liposculptor IIE - Product Description
Table 13: Airbrush Liposculptor IIIE - Product Status
Table 14: Airbrush Liposculptor IIIE - Product Description
Table 15: NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: NivaSonix ULLISYS - Product Status
Table 17: NivaSonix ULLISYS - Product Description
Table 18: Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Ultrasound Body Shaping Device - Product Status
Table 20: Ultrasound Body Shaping Device - Product Description
Table 21: Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: CoolAdhesive Gelpad - Product Status
Table 23: CoolAdhesive Gelpad - Product Description
Table 24: CoolAdvantage Petite Applicator - Product Status
Table 25: CoolAdvantage Petite Applicator - Product Description
Table 26: Zeltiq Applicator - Cellulite - Product Status
Table 27: Zeltiq Applicator - Cellulite - Product Description
Table 28: Glossary
1.2 List of Figures
Figure 1: Body Contouring - Pipeline Products by Stage of Development
Figure 2: Body Contouring - Pipeline Products by Territory
Figure 3: Body Contouring - Pipeline Products by Regulatory Path
Figure 4: Body Contouring - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report